Literature DB >> 9825880

Proton-pump inhibitors in acid-related diseases.

R R Berardi1, L S Welage.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9825880     DOI: 10.1093/ajhp/55.21.2289

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  7 in total

1.  Esomeprazole: a review of its use in the management of acid-related disorders in the US.

Authors:  Lesley J Scott; Christopher J Dunn; Gordon Mallarkey; Miriam Sharpe
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Lansoprazole: an update of its place in the management of acid-related disorders.

Authors:  A J Matheson; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Rabeprazole: a review of its use in acid-related gastrointestinal disorders.

Authors:  H D Langtry; A Markham
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

4.  Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.

Authors:  Yohannes T Ghebremariam; Paea LePendu; Jerry C Lee; Daniel A Erlanson; Anna Slaviero; Nigam H Shah; James Leiper; John P Cooke
Journal:  Circulation       Date:  2013-07-03       Impact factor: 29.690

Review 5.  Esomeprazole: a review of its use in the management of acid-related disorders.

Authors:  Lesley J Scott; Christopher J Dunn; Gordon Mallarkey; Miriam Sharpe
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  Switching between intravenous and oral pantoprazole.

Authors:  J R Pisegna
Journal:  J Clin Gastroenterol       Date:  2001-01       Impact factor: 3.062

7.  Effects of high-dose versus low-dose proton pump inhibitors for treatment of gastrointestinal ulcer bleeding: a meta-analysis of randomized controlled trials.

Authors:  Wei Zhu; Liang Chen; Jian Zhang; Pei Wang
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.